A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)

NCT04787328 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Medullary Thyroid Carcinoma

Interventions

DRUG: HA121-28 tablets

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.